• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分化型甲状腺癌患者复发预测的评分系统。

A scoring system to predict recurrence in patients with differentiated thyroid cancer.

机构信息

Department of Otolaryngology, General University Hospital of Elda, Elda, Alicante, Spain.

Department of Clinical Medicine, Miguel Hernández University, San Juan de Alicante, Alicante, Spain.

出版信息

Clin Otolaryngol. 2019 Jan;44(1):26-31. doi: 10.1111/coa.13227. Epub 2018 Oct 9.

DOI:10.1111/coa.13227
PMID:30220101
Abstract

OBJECTIVES

Though predictive models have been constructed to determine the risk of recurrence in differentiated thyroid carcinoma, various aspects of these models are inadequate. Therefore, we aimed to construct, internally validate and implement on a mobile application a scoring system to determine this risk within 10 years.

DESIGN

A retrospective cohort study in 1984-2016.

SETTING

A Spanish region.

PARTICIPANTS

We enrolled 200 patients with differentiated thyroid carcinoma without distant metastasis at diagnosis.

MAIN OUTCOME MEASURES

Time-to-recurrence. A risk table was constructed based on the sum of points to estimate the likelihood of recurrence. The model was internally validated and implemented as a mobile application for Android.

RESULTS

Predictive factors were follicular histology, T, N and multifocality. This risk table had a C-statistic of 0.723. The calibration was satisfactory.

CONCLUSIONS

This study provides an instrument able to predict rapidly and very simply which patients with differentiated thyroid carcinoma have a greater risk of recurrence.

摘要

目的

尽管已经构建了预测模型来确定分化型甲状腺癌的复发风险,但这些模型的各个方面都存在不足。因此,我们旨在构建、内部验证并在移动应用程序上实施一种评分系统,以在 10 年内确定这种风险。

设计

一项回顾性队列研究,时间为 1984 年至 2016 年。

地点

西班牙一个地区。

参与者

我们纳入了 200 例初诊时无远处转移的分化型甲状腺癌患者。

主要观察指标

复发时间。根据积分总和构建风险表,以估计复发的可能性。对模型进行了内部验证,并作为 Android 移动应用程序实现。

结果

预测因素为滤泡状组织学、T、N 和多灶性。该风险表的 C 统计量为 0.723。校准结果令人满意。

结论

本研究提供了一种快速且非常简单的工具,能够预测分化型甲状腺癌患者中哪些患者具有更高的复发风险。

相似文献

1
A scoring system to predict recurrence in patients with differentiated thyroid cancer.分化型甲状腺癌患者复发预测的评分系统。
Clin Otolaryngol. 2019 Jan;44(1):26-31. doi: 10.1111/coa.13227. Epub 2018 Oct 9.
2
Scoring System for Mortality in Patients Diagnosed with and Treated Surgically for Differentiated Thyroid Carcinoma with a 20-Year Follow-Up.接受手术治疗的分化型甲状腺癌患者死亡率评分系统:20年随访研究
PLoS One. 2015 Jun 26;10(6):e0128620. doi: 10.1371/journal.pone.0128620. eCollection 2015.
3
A predictive model for recurrence in patients with glottic cancer implemented in a mobile application for Android.用于 Android 移动应用程序的声门型癌症患者复发预测模型。
Oral Oncol. 2018 May;80:82-88. doi: 10.1016/j.oraloncology.2018.03.021. Epub 2018 Apr 4.
4
Early recurrence of papillary and follicular thyroid carcinoma predicts a worse outcome.甲状腺乳头状癌和滤泡状癌的早期复发预示着更差的预后。
Thyroid. 2009 Oct;19(10):1053-9. doi: 10.1089/thy.2009.0133.
5
Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.同质管理的pT3分化型甲状腺癌人群中的复发风险。
Langenbecks Arch Surg. 2018 May;403(3):325-332. doi: 10.1007/s00423-018-1657-2. Epub 2018 Feb 14.
6
[Poorly differentiated thyroid follicular carcinoma - a clinical analysis of 30 cases].[低分化甲状腺滤泡癌——30例临床分析]
Ai Zheng. 2004 Sep;23(9):1081-4.
7
A one-year risk score to predict all-cause mortality in hypertensive inpatients.预测高血压住院患者全因死亡率的一年风险评分。
Eur J Intern Med. 2019 Jan;59:77-83. doi: 10.1016/j.ejim.2018.07.010. Epub 2018 Jul 13.
8
Implementing the Modified 2009 American Thyroid Association Risk Stratification System in Thyroid Cancer Patients with Low and Intermediate Risk of Recurrence.在低复发风险和中复发风险的甲状腺癌患者中实施改良的 2009 年美国甲状腺协会风险分层系统。
Thyroid. 2015 Nov;25(11):1235-42. doi: 10.1089/thy.2015.0121. Epub 2015 Aug 6.
9
Management and outcome of recurrent well-differentiated thyroid carcinoma.复发性高分化甲状腺癌的管理与预后
Arch Otolaryngol Head Neck Surg. 2004 Jul;130(7):819-24. doi: 10.1001/archotol.130.7.819.
10
Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer.预后因素及风险分组在分化型甲状腺癌管理中的意义
Laryngoscope. 2004 Mar;114(3):393-402. doi: 10.1097/00005537-200403000-00001.